{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:39:26Z","timestamp":1789166366040,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00210-024-03299-x","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T03:01:47Z","timestamp":1721703707000},"page":"629-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antiepileptic profile of Parawixin-11, purified from Parawixia bistriata spider venom (Araneae, Araneidae), in Wistar rats"],"prefix":"10.1007","volume":"398","author":[{"given":"Adriana Colsera","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Olimpio Siqueira","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia Renata","family":"Mortari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene Aparecida","family":"Fachim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Avohay Alves","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto Peporine","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner Ferreira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"3299_CR1","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1124\/mol.105.017319","volume":"69","author":"RO Beleboni","year":"2006","unstructured":"Beleboni RO, Guizzo R, Fontana ACK, Pizzo AB, Carolino RO, Gobbo-Neto L, Lopes NP, Coutinho-Netto J, Santos WF (2006) Neurochemical characterization of a neuroprotective compound from Parawixia bistriata spider venom that inhibits synaptosomal uptake of GABA and glycine. Mol Pharmacol 69:1998\u20132006. https:\/\/doi.org\/10.1124\/mol.105.017319","journal-title":"Mol Pharmacol"},{"key":"3299_CR2","doi-asserted-by":"publisher","unstructured":"Beleboni RO, Mortari MR, Melo-Thomas L, Coimbra NC (2022) Classical and modern biotechnology applied to the treatment of epilepsy and anxiety disorders. Front\u00a0Pharmacol 12:824986. https:\/\/doi.org\/10.3389\/fphar.2021.824986","DOI":"10.3389\/fphar.2021.824986"},{"key":"3299_CR3","doi-asserted-by":"publisher","unstructured":"Beleboni RO, Pizzo AB, Fontana ACK, Carolino ROG, Coutinho-Netto J, Santos WF (2004) Spider and wasp neurotoxins: pharmacological and biochemical aspects. Eur J Pharmacol 17:1\u201317. https:\/\/doi.org\/10.1016\/j.ejphar.2004.03.049","DOI":"10.1016\/j.ejphar.2004.03.049"},{"key":"3299_CR4","doi-asserted-by":"publisher","unstructured":"Brancati VU, Vraca PV, Minutoli L, Pallio G (2023) Polymorphisms affecting the response to novel antiepileptic drugs. Int J Mol Sci 24(3):2535. https:\/\/doi.org\/10.3390\/ijms24032535","DOI":"10.3390\/ijms24032535"},{"key":"3299_CR5","doi-asserted-by":"publisher","unstructured":"Bubser M, Keseberg U, Notz PK, Schmidt WJ (1992) Differential behavioural and neurochemical effects of competitive and noncompetitive NMDA receptor antagonists in rats. Eur J Pharmacol 229:75\u201382. https:\/\/doi.org\/10.1016\/0014-2999(92)90288-f","DOI":"10.1016\/0014-2999(92)90288-f"},{"key":"3299_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1076\/phbi.40.6.472.8436","volume":"40","author":"MAR Cairr\u00e3o","year":"2002","unstructured":"Cairr\u00e3o MAR, Ribeiro AM, Pizzo AB, Fontana ACK, Beleboni RO, Coutinho-Netto J, Miranda A, Santos WF (2002) Anticonvulsant and GABA uptake inhibition properties of P. bistriata and S. raptoria spider venom fractions. Pharmacol Biol 40:472\u2013477. https:\/\/doi.org\/10.1076\/phbi.40.6.472.8436","journal-title":"Pharmacol Biol"},{"issue":"3","key":"3299_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/1389450013348515","volume":"2","author":"C Castellano","year":"2001","unstructured":"Castellano C, Cestari V, Ciamei A (2001) NMDA receptors and learning and memory processes. Curr Drug Targets 2(3):273\u201383. https:\/\/doi.org\/10.2174\/1389450013348515","journal-title":"Curr Drug Targets"},{"key":"3299_CR8","doi-asserted-by":"publisher","unstructured":"Chow CY, Absalom N, Biggs K, King GF, Ma L (2020) Venom-derived modulators of epilepsy-related\u00a0ion\u00a0channels. Biochem Pharmacol 181:114043. https:\/\/doi.org\/10.1016\/j.bcp.2020.114043","DOI":"10.1016\/j.bcp.2020.114043"},{"key":"3299_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0091-3057(94)90506-1","volume":"48","author":"W Danysz","year":"1994","unstructured":"Danysz W, Essmann U, Bresink I, Wilke R (1994) Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav 48:111\u2013118. https:\/\/doi.org\/10.1016\/0091-3057(94)90506-1","journal-title":"Pharmacol Biochem Behav"},{"key":"3299_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yebeh.2011.05.008","volume":"22","author":"HA Fachim","year":"2011","unstructured":"Fachim HA, Cunha AO, Pereira AC, Beleboni RO, Gobbo-Neto L, Lopes NO, Coutinho-Netto J, dos Santos WF (2011) Neurobiological activity of Parawixin 10, a novel anticonvulsant compound isolated from Parawixia bistriata spider venom (Araneidae: Araneae). Epilepsy Behav 22:158\u201364. https:\/\/doi.org\/10.1016\/j.yebeh.2011.05.008","journal-title":"Epilepsy Behav"},{"key":"3299_CR11","doi-asserted-by":"publisher","unstructured":"Fattorusso A, Matricardi S, Mencaroni E, Dell\u2019Isola GB, Di Cara G, Striano P, Verrotti A (2021) The pharmacoresistant epilepsy: an overview on existent and new emerging therapies. Front Neurol 12:674483. https:\/\/doi.org\/10.3389\/fneur.2021.674483","DOI":"10.3389\/fneur.2021.674483"},{"key":"3299_CR12","unstructured":"Finney, D J. (1971) Probit analysis, 3rd Edition. Cambridge University Press, London, p 368"},{"key":"3299_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/sj.bjp.0705352","volume":"139","author":"AC Fontana","year":"2003","unstructured":"Fontana AC, Guizzo R, Beleboni RO, Meirelles e Silva AR, Coimbra NC, Amara SG, Santos WF, Coutinho-Neto J, (2003) Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake. Br J Pharmacol 139:1297\u20131309. https:\/\/doi.org\/10.1038\/sj.bjp.0705352","journal-title":"Br J Pharmacol"},{"issue":"5","key":"3299_CR14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1124\/mol.107.037127","volume":"72","author":"AC Fontana","year":"2007","unstructured":"Fontana AC, Beleboni RO, Wojewodzic MW, dos Santos WF, Coutinho-Netto J, Grutle NJ, Watts SD, Danbolt NC, Amara SG (2007) Enhancing glutamate transport: mechanism of action of parawixin1, a neuroprotective compound from Parawixia bistriata spider venom. Mol Pharmacol 72(5):1228\u201337. https:\/\/doi.org\/10.1124\/mol.107.037127","journal-title":"Mol Pharmacol"},{"key":"3299_CR15","doi-asserted-by":"publisher","unstructured":"Forster YM, Green JL, Khatiwada A, Liberato JL, Narayana Reddy PA, Salvino JM, Bienz S, Bigler L, Dos Santos WF, Karklin Fontana AC (2020) Elucidation of the structure and synthesis of neuroprotective low molecular mass components of the Parawixia bistriata spider venom. ACS Chem Neurosci (11):1573\u20131596. https:\/\/doi.org\/10.1021\/acschemneuro.0c00007","DOI":"10.1021\/acschemneuro.0c00007"},{"issue":"12","key":"3299_CR16","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.4103\/1673-5374.373714","volume":"18","author":"SG Gaidin","year":"2023","unstructured":"Gaidin SG, Kosenkov AM (2023) Calcium-permeable AMPA receptors: an underestimated pharmacological target for the therapy of brain pathologies. Neural Regen Res 18(12):2669\u201370. https:\/\/doi.org\/10.4103\/1673-5374.373714","journal-title":"Neural Regen Res"},{"key":"3299_CR17","doi-asserted-by":"publisher","unstructured":"Gazerani P (2024) Can venoms be used in neuroprotection? Chapter 3. In: Natural molecules in neuroprotection and neurotoxicity. Elsevier Inc. https:\/\/doi.org\/10.1016\/B978-0-443-23763-8.00003-8","DOI":"10.1016\/B978-0-443-23763-8.00003-8"},{"key":"3299_CR18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.lfs.2006.10.002","volume":"80","author":"EA Gelfuso","year":"2007","unstructured":"Gelfuso EA, Cunha AO, Mortari MR, Liberato JL, Paraventi KH, Beleboni RO, Coutinho-Netto J, Lopes NP, dos Santos WF (2007) Neuropharmacological profile of FrPbAII, purified from the venom of the social spider Parawixia bistriata (Araneae, Araneidae), in Wistar rats. Life Sci 80:566\u201372. https:\/\/doi.org\/10.1016\/j.lfs.2006.10.002","journal-title":"Life Sci"},{"key":"3299_CR19","doi-asserted-by":"publisher","unstructured":"Green JL, Dos Santos WF, Fontana ACK (2021) Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development. Biochem Pharmacol 193:114786. https:\/\/doi.org\/10.1016\/j.bcp.2021.114786","DOI":"10.1016\/j.bcp.2021.114786"},{"key":"3299_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s0014-2999(03)02182-4","volume":"476","author":"MR Guscott","year":"2003","unstructured":"Guscott MR, Clarke HF, Murray F, Grimwood S, Bristow LJ, Hutson PH (2003) The effect of (+\/-)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze. Eur J Pharmacol 476:193\u20139. https:\/\/doi.org\/10.1016\/s0014-2999(03)02182-4","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"3299_CR21","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2174\/1570159X19666210211150856","volume":"19","author":"YC Kaplan","year":"2021","unstructured":"Kaplan YC, Demir O (2021) Use of phenytoin, phenobarbital carbamazepine, levetiracetam lamotrigine and valproate in pregnancy and breastfeeding: risk of major malformations, dose-dependency, monotherapy vs polytherapy, pharmacokinetics and clinical implications. Curr Neuropharmacol 19(11):1805\u20131824. https:\/\/doi.org\/10.2174\/1570159X19666210211150856","journal-title":"Curr Neuropharmacol"},{"key":"3299_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2199874","volume":"12","author":"P Kumar","year":"2023","unstructured":"Kumar P, Sheokand D, Grewal A, Saini V, Kumar A (2023) Clinical side-effects based drug repositioning for anti-epileptic activity. J Biomol Struct Dyn 12:1\u201312. https:\/\/doi.org\/10.1080\/07391102.2023.2199874","journal-title":"J Biomol Struct Dyn"},{"key":"3299_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1006\/ebeh.2000.0085","volume":"1","author":"Y Lamberty","year":"2000","unstructured":"Lamberty Y, Klingaard H (2000) Consequences of pentylenotetrazole-induced kindling on spational memory and emotional responding in the rat. Epilepsy Behav 1:256\u201361. https:\/\/doi.org\/10.1006\/ebeh.2000.0085","journal-title":"Epilepsy Behav"},{"key":"3299_CR24","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1002\/jnr.25114","volume":"100","author":"LS Lima","year":"2022","unstructured":"Lima LS, Loyola V, Bicca JVM, Faro L, Vale CLC, Lotufo Denucci B, Mortari MR (2022) Innovative treatments for epilepsy: venom peptides, cannabinoids, and neurostimulation. J Neurosci Res 100:1969\u20131986. https:\/\/doi.org\/10.1002\/jnr.25114","journal-title":"J Neurosci Res"},{"issue":"1","key":"3299_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0014-2999(97)01514-8","volume":"342","author":"W L\u00f6scher","year":"1998","unstructured":"L\u00f6scher W (1998) New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342(1):1\u201313. https:\/\/doi.org\/10.1016\/s0014-2999(97)01514-8","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"3299_CR26","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40263-021-00853-6","volume":"35","author":"W L\u00f6scher","year":"2021","unstructured":"L\u00f6scher W, Klein P (2021) The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond. CNS drugs 35(9):935\u201363. https:\/\/doi.org\/10.1007\/s40263-021-00853-6","journal-title":"CNS drugs"},{"key":"3299_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.toxicon.2004.02.003","volume":"43","author":"IR Mellor","year":"2004","unstructured":"Mellor IR, Usherwood PNR (2004) Targeting ionotropic receptors with polyamine-containing toxins. Toxicon 43:493\u2013508. https:\/\/doi.org\/10.1016\/j.toxicon.2004.02.003","journal-title":"Toxicon"},{"key":"3299_CR28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/297681a0","volume":"297","author":"RP Morris","year":"1982","unstructured":"Morris RP, Garrud P, Rawlins JNP, O\u2019Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681\u2013683. https:\/\/doi.org\/10.1038\/297681a0","journal-title":"Nature"},{"key":"3299_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pharmthera.2007.01.009","volume":"114","author":"MR Mortari","year":"2007","unstructured":"Mortari MR, Cunha AOS, Ferreira LB, Santos WF (2007) Neurotoxins from invertebrates as anticonvulsants: from basic research to therapeutic application. Pharmacol Ther 114:171\u201383. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.01.009","journal-title":"Pharmacol Ther"},{"key":"3299_CR30","doi-asserted-by":"publisher","unstructured":"Mortari MR, Cunha AOS, Dos Anjos LC, Amaral HO, Quintanilha MVT, Gelfuso EA, Homem-de-Mello M, de Almeida H, Rego S, Maigret B, Lopes NP, Dos Santos WF (2023) A new class of peptides from wasp venom: a pathway to antiepileptic\/neuroprotective drugs. Brain Commun 5(1):fcad016. https:\/\/doi.org\/10.1093\/braincomms\/fcad016","DOI":"10.1093\/braincomms\/fcad016"},{"key":"3299_CR31","unstructured":"Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. (Third Edition). 286 p. Academic Press, Inc. Sidney. International Standard Book Number: 0-12-547623-X"},{"issue":"4","key":"3299_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1684\/epd.2019.1083","volume":"21","author":"E Perucca","year":"2019","unstructured":"Perucca E (2019) Antiepileptic drugs: evolution of our knowledge and changes in drug trials. Epileptic Disord 21(4):319\u2013329. https:\/\/doi.org\/10.1684\/epd.2019.1083","journal-title":"Epileptic Disord"},{"key":"3299_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0014-4886(78)90133-4","volume":"58","author":"JP Pinel","year":"1978","unstructured":"Pinel JP, Rovner LI (1978) Experimental epileptogenesis; kindling-induced epilepsy in rats. Exp Neurol 58:190\u2013202. https:\/\/doi.org\/10.1016\/0014-4886(78)90133-4","journal-title":"Exp Neurol"},{"issue":"3","key":"3299_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ (1972) Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 32(3):281\u201394. https:\/\/doi.org\/10.1016\/0013-4694(72)90177-0","journal-title":"Motor seizure. Electroencephalogr Clin Neurophysiol"},{"key":"3299_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/BF00229142","volume":"110","author":"J Speller","year":"1996","unstructured":"Speller J, Westby GWM (1996) Bicuculline-induced circling from the rat superior colliculus is blocked by GABA microinjection into deep cerebellar nuclei. Exp Brain Res 110:425\u2013434. https:\/\/doi.org\/10.1007\/BF00229142","journal-title":"Exp Brain Res"},{"issue":"10172","key":"3299_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs RD, Surges R, O\u2019Brien TJ, Sander JW (2019) Epilepsy in adults. Lancet 393(10172):689\u2013701. https:\/\/doi.org\/10.1016\/S0140-6736(18)32596-0","journal-title":"Lancet"},{"key":"3299_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0163-7258(91)90012-b","volume":"52","author":"PNR Usherwood","year":"1994","unstructured":"Usherwood PNR, Blagbrough IS (1994) Spider toxins affecting glutamate receptors: Polyamines in therapeutic neurochemistry. Pharmacol Teratol 52:245\u2013268. https:\/\/doi.org\/10.1016\/0163-7258(91)90012-b","journal-title":"Pharmacol Teratol"},{"key":"3299_CR38","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1134\/s0006297909130069","volume":"74","author":"AA Vassilevski","year":"2009","unstructured":"Vassilevski AA, Kozlov SA, Grishin EV (2009) Molecular diversity of spider venom. Biochemistry 74:1505\u20131534. https:\/\/doi.org\/10.1134\/s0006297909130069","journal-title":"Biochemistry"},{"key":"3299_CR39","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/ph3072090","volume":"3","author":"A Wahab","year":"2010","unstructured":"Wahab A (2010) Difficulties in treatment and management of epilepsy and challenges in new drug development. Pharmaceuticals 3:2090\u20132110. https:\/\/doi.org\/10.3390\/ph3072090","journal-title":"Pharmaceuticals"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03299-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03299-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03299-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T04:04:44Z","timestamp":1738382684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03299-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3299"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03299-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4294856\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Protocol number 081.1.182.53.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}